Cresco Labs Inc
Latest Cresco Labs Inc News and Updates
Cannabis To Buy or Not to Buy the Dip on Cresco Labs (CRLBF) Stock
Cresco Labs stock is down 36 percent from its 52-week high. Why is CRLBF stock dropping and will it recover in 2021?Cannabis Cresco Labs Stock Is a Buy Due to Strong Growth Prospects
Cresco Labs (CRLBF) stock has lost 12 percent in the last five trading sessions. What’s the forecast for CRLBF stock?Miscellaneous Cresco Labs Gets Another ‘Buy’ Rating
Yesterday, Eight Capital initiated coverage on Cresco Labs (CRLBF) with a “buy” rating.Cannabis Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.Cannabis Marijuana Legalization Still Has a Chance in Idaho
Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.Cannabis Cannabis Market in Illinois Grows, Challenges Remain
The growth in Illinois’s cannabis market is evident from its record sales in May. The state sold adult-use cannabis worth $44.3 million in May.Cannabis MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.Cannabis Cannabis Market Has Good Potential in Illinois
The cannabis market in Illinois has been growing despite the COVID-19 pandemic. Illinois legalized recreational cannabis on January 1, 2020.Cannabis Marijuana Legalization Attempts in New York amid Protests
George Floyd’s death has led to mass protests in the US. Notably, social injustice was one of the main motives behind legalizing marijuana.Cannabis MedMen Temporarily Closes Stores amid Protests
Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.Cannabis Will MedMen’s Q3 2020 Earnings Be a Relief?
MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.Cannabis Curaleaf: Analysts’ Recommendations after Its Q1 Earnings
Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.Cannabis Why Is There Optimism before Cresco Labs’ Q4 Earnings?
Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.Cannabis How Will Curaleaf Benefit from Acquiring BlueKudu?
On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.Cannabis GW Pharmaceuticals Provides Preliminary Sales Update
On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.Cannabis TerrAscend Private Placement Oversubscribed
TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.Cannabis Marijuana in Hawaii: Is Further Legalization Likely?
We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.Cannabis Cannabis Stocks Rise: CURLF, IIPR, ACB, WEED
After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.Cannabis Cresco Labs Stock Tumbling ahead of Earnings
Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company’s stock fell 5.3% yesterday.